< 1 minute read
Nov. 3, 2021
EC5026: An Oral Soluble Epoxide Hydrolase Inhibitor
EC5026
pM oral sEH epoxide hydrolase inhibitor completed Ph. I HV study + in animal health epoxide-opening transition-state mimic J. Med. Chem., Feb. 7, 2021 EicOsis Human Health Inc., Davis, CA